Focal segmental glomerulosclerosis ( FSGS ) is a histopathologic finding of scarring (sclerosis) of glomeruli and damage to renal podocytes . This process damages the filtration function of the kidney, resulting in protein presence in the urine due to protein loss. FSGS is a leading cause of excess protein loss— nephrotic syndrome —in children and adults in the US. Signs and symptoms include proteinuria and edema . Kidney failure is a common long-term complication of the disease. FSGS can be classified as primary, secondary, or genetic, depending on whether a particular toxic or pathologic stressor or genetic predisposition can be identified as the cause. Diagnosis is established by renal biopsy, and treatment consists of glucocorticoids and other immune-modulatory drugs. Response to therapy is variable, with a significant portion of patients progressing to end-stage kidney failure. An American epidemiological study 20 years ago demonstrated that FSGS is estimated to occur in 7 persons per million, with cisgender male African-Americans at higher risk.
74-445: The most common symptoms are a result of abnormal loss of protein from the glomerulus of the kidney, and include: Common signs are also due to loss of blood proteins by the glomerulus of the kidney, including: FSGS is primarily a disease of the renal glomerulus , the site of filtration of ions and solutes. Podocytes are specialized cells lining the Bowman's capsule that contribute to
148-474: A 50% rate of progression to end-stage kidney disease at 10 years. Only 15% of patients with sub-nephrotic ranges of proteinuria progress to end-stage renal failure at 10 years. Initial response to therapy also dictates long-term outcomes. Those defined as having a "complete response" typically manifest a proteinuria of <300 mg/day; those with a "partial response" manifest a sub-nephrotic range of proteinuria, <3.5 g/day. Either complete or partial response
222-620: A CKDu referred to as the Mesoamerican nephropathy (MeN). It was estimated in 2013 that at least 20,000 men had died prematurely, some in their 20s and 30s; a figure of 40,000 per year was estimated in 2020. In some affected areas CKD mortality was five times the national rate. MeN primarily affects men working as sugarcane labourers. The cause is unknown, but in 2020 the science found a clearer connection between heavy labour in high temperatures and incidence of CKDu; improvements such as regular access to water, rest and shade, can significantly decrease
296-400: A diagnosis of FSGS, although these do not help to distinguish between FSGS and other causes of proteinuria. Five mutually exclusive variants of focal segmental glomerulosclerosis may be distinguished by the pathologic findings seen on renal biopsy : Recognition of these variants may have prognostic value in individuals with primary focal segmental glomerulosclerosis. The collapsing variant
370-691: A family history of chronic kidney disease. Diagnosis is by blood tests to measure the estimated glomerular filtration rate (eGFR), and a urine test to measure albumin . Ultrasound or kidney biopsy may be performed to determine the underlying cause. Several severity-based staging systems are in use. Screening at-risk people is recommended. Initial treatments may include medications to lower blood pressure, blood sugar, and cholesterol. Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin II receptor antagonists (ARBs) are generally first-line agents for blood pressure control, as they slow progression of
444-451: A gradual transition can help preserve remaining kidney function. More research is ongoing to improve CKD management and patient outcomes. Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin II receptor antagonists (ARBs) are recommended as first-line agents since they have been found to slow the decline of kidney function, relative to a more rapid decline in those not on one of these agents. They have also been found to reduce
518-610: A high-flux membrane, hemodiafiltration and hemofiltration. However, conventional dialysis treatment is limited in its ability to remove protein-bound uremic toxins. CKD increases the risk of cardiovascular disease, and people with CKD often have other risk factors for heart disease, such as high blood lipids . The most common cause of death in people with CKD is cardiovascular disease rather than kidney failure. Chronic kidney disease results in worse all-cause mortality (the overall death rate) which increases as kidney function decreases. The leading cause of death in chronic kidney disease
592-439: A history of kidney disease in the past, and subjects who have relatives who had kidney disease requiring dialysis. Screening should include calculation of the estimated GFR (eGFR) from the serum creatinine level, and measurement of urine albumin-to-creatinine ratio (ACR) in a first-morning urine specimen (this reflects the amount of a protein called albumin in the urine), as well as a urine dipstick screen for hematuria. The GFR
666-426: A kidney disease, or when following up a case with known kidney disease, or when risking a development of renal damage such as beginning medications with known nephrotoxicity . In 1666, Italian biologist and anatomist Marcello Malpighi first described the glomeruli and demonstrated their continuity with the renal vasculature (281,282). About 175 years later, surgeon and anatomist William Bowman elucidated in detail
740-423: A kidney transplant for survival. Chronic kidney disease affected 753 million people globally in 2016 (417 million females and 336 million males.) In 2015, it caused 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000. CKD is initially without symptoms, and
814-763: A negative impact in CKD, increasing the risk of disease progression to ESKD or kidney failure compared to controls with healthy weight, and when in advanced stages also may hinder people's eligibility to kidney transplantation . For example, the consumption of high calorie and high fructose beverages can make an individual "60% more likely to develop CKD". Weight management interventions in overweight and obese adults with CKD include lifestyle inverventions (dietary changes, physical activity / exercise , or behavioural strategies), pharmacological (used to reduce absorption or suppress appetite ) and surgical interventions. Any of these can help people with CKD loose weight, however, it
SECTION 10
#1732858929420888-554: A reference range may reinforce stereotypes and perpetuate health disparities. This approach fails to account for the complex interplay of genetic, environmental, and social factors influencing kidney function. Depending solely on race-based metrics may lead to misdiagnosis or underdiagnosis in minority populations. Alternative approaches that consider socioeconomic status, environmental exposures, and genetic vulnerability, are needed to accurately assess kidney function and address CKD care disparities. The International Society of Nephrology
962-562: A role in the pathogenesis of this disease. Diagnosis of FSGS is made by renal biopsy that includes at least fifteen serial cuts with at least eight glomeruli . Histologic features include sclerosis (scarring) of a portion (average: 15%) of the glomerular space, with only a portion of glomeruli manifesting any sclerosis. Other tests helpful in the diagnosis include urine protein, urinalysis, serum albumin, and serum lipids. A clinical picture of proteinuria , low blood protein levels (albumin, antibodies), and high blood cholesterol would support
1036-528: A sudden increase in the serum creatinine (several days to weeks). In many people with CKD, previous kidney disease or other underlying diseases are already known. A significant number present with CKD of unknown cause. Screening those who have neither symptoms nor risk factors for CKD is not recommended. Those who should be screened include: those with hypertension or history of cardiovascular disease, those with diabetes or marked obesity, those aged > 60 years, subjects with African American ancestry, those with
1110-521: A unique structure: there are pores between the cells that allow water and soluble substances to exit and after passing through the glomerular basement membrane and between digitating podocyte foot processes , enter the capsule as ultrafiltrate. Capillaries of the glomerulus are lined by endothelial cells . These contain numerous pores—also called fenestrae —, 50–100 nm in diameter. Unlike those of other capillaries with fenestrations, these fenestrations are not spanned by diaphragms. They allow for
1184-448: Is 250–400 nm in thickness, which is thicker than basement membranes of other tissue. It is a barrier to blood proteins such as albumin and globulin . The part of the podocyte in contact with the glomerular basement membrane is called a podocyte foot process or pedicle (Fig. 3): there are gaps between the foot processes through which the filtrate flows into Bowman's capsule. The space between adjacent podocyte foot processes
1258-404: Is a common complication from CKD. Children with CKD will be shorter than 97% of children the same age and sex. This can be treated with additional nutritional support, or medication such as growth hormone . Survival rates of CKD are generally longer with dialysis than without (having only conservative kidney management). However, from the age of 80 and in elderly patients with comorbidities there
1332-399: Is a network of small blood vessels ( capillaries ) known as a tuft , located at the beginning of a nephron in the kidney . Each of the two kidneys contains about one million nephrons. The tuft is structurally supported by the mesangium (the space between the blood vessels), composed of intraglomerular mesangial cells . The blood is filtered across the capillary walls of this tuft through
1406-473: Is a scenario of excess filtration by renal glomeruli. Hyperfiltration can be caused by obesity, diabetes or loss of the contralateral kidney, among other causes. Secondary FSGS can also be caused by toxins, including anabolic steroids and heroin. A number of genes have been implicated in FSGS. These include: NPHS1 , which encodes the protein nephrin that contributes to the filtration barrier; NPHS2 , which encodes
1480-496: Is a serious condition often linked to diabetes and high blood pressure. There is no cure, but a combination of lifestyle changes and medications can help slow its progression. This might include a plant-dominant diet with less protein and salt, medications to control blood pressure and sugar, and potentially newer anti-inflammatory drugs. Doctors may also focus on managing heart disease risk, preventing infections, and avoiding further kidney damage. While dialysis may eventually be needed,
1554-442: Is a tuft of capillaries located within Bowman's capsule within the kidney. Glomerular mesangial cells structurally support the tufts. Blood enters the capillaries of the glomerulus by a single arteriole called an afferent arteriole and leaves by an efferent arteriole . The capillaries consist of a tube lined by endothelial cells with a central lumen . The gaps between these endothelial cells are called fenestrae. The walls have
SECTION 20
#17328589294201628-613: Is an international body representing specialists in kidney diseases. It was said to be costing the National Health Service about £1.5 billion a year in 2020. Kidney Care UK and The UK National Kidney Federation represent people with chronic kidney disease. The Renal Association represents Kidney physicians and works closely with the National Service Framework for kidney disease. Kidney Health Australia serves that country. The incidence rate of CKD in dogs
1702-580: Is associated with 80% kidney survival at 10 years, compared with about 50% among non-responsive patients. FSGS accounts for 35% of all cases of nephrotic syndrome , making it one of the most common causes of nephrotic syndrome in the United States. FSGS accounts for 2% of all cases of kidney failure. African American patients have four times the likelihood of developing FSGS. Men are about two times as likely to develop FSGS compared to women. Glomerulus (kidney) The glomerulus ( pl. : glomeruli )
1776-766: Is associated with higher rate of progression to end-stage renal disease , whereas the glomerular tip lesion variant has a low rate of progression to end-stage renal disease in most patients. The cellular variant shows similar clinical presentation to collapsing and glomerular tip variant but has intermediate outcomes between the other two variants. First-line treatment for primary FSGS consists of anti-inflammatory drugs. Specifically, glucocorticoids are begun in patients manifesting with nephrotic -range proteinuria (>3.5 g/day). For patients who maintain nephrotic-range proteinuria despite glucocorticoids, or for patients who demonstrate glucocorticoid intolerance, calcineurin inhibitors (e.g., tacrolimus) are initiated. Successful treatment
1850-426: Is cardiovascular disease, regardless of whether there is progression to stage 5. While kidney replacement therapies can maintain people indefinitely and prolong life, the quality of life is negatively affected. Kidney transplantation increases the survival of people with stage 5 CKD when compared to other options; however, it is associated with an increased short-term mortality due to complications of
1924-450: Is common and intensity of end-of-life care is highly variable among people opting out of dialysis. About one in ten people have chronic kidney disease. In Canada 1.9 to 2.3 million people were estimated to have CKD in 2008. CKD affected an estimated 16.8% of U.S. adults aged 20 years and older in the period from 1999 to 2004. In 2007 8.8% of the population of Great Britain and Northern Ireland had symptomatic CKD. Chronic kidney disease
1998-490: Is considered normal without chronic kidney disease if there is no kidney damage present. Kidney damage is defined signs of damage seen in blood, urine, or imaging studies which includes lab albumin/creatinine ratio (ACR) ≥ 30. All people with a GFR <60 mL/min/1.73 m for 3 months are defined as having chronic kidney disease. Protein in the urine is regarded as an independent marker for worsening of kidney function and cardiovascular disease. Hence, British guidelines append
2072-409: Is defined as a drop in proteinuria to sub-nephrotic ranges. The treatment of secondary FSGS involves addressing the particular toxic or stress agent. The majority of untreated cases of FSGS will progress to end-stage kidney disease . Important prognostic factors include the degree of proteinuria and initial response to therapy. Patients with nephrotic -range (>3.5 g/day) proteinuria have over
2146-447: Is derived from the serum creatinine and is proportional to 1/creatinine, i.e. it is a reciprocal relationship; the higher the creatinine, the lower the GFR. It reflects one aspect of kidney function, how efficiently the glomeruli – the filtering units – work. The normal GFR is 90–120 ml/min. The units of creatinine vary from country to country, but since the glomeruli make up <5% of the mass of
2220-661: Is determined (as in systemic capillaries) by the Starling equation : The walls of the afferent arteriole contain specialized smooth muscle cells that synthesize renin . These juxtaglomerular cells play a major role in the renin–angiotensin system , which helps regulate blood volume and pressure . Damage to the glomerulus by disease can allow passage through the glomerular filtration barrier of red blood cells, white blood cells, platelets, and blood proteins such as albumin and globulin. Underlying causes for glomerular injury can be inflammatory, toxic or metabolic. These can be seen in
2294-467: Is glomerular sclerosis, tubular atrophy, interstitial fibrosis, or inflammation, the result is often increased echogenicity of the cortex. The echogenicity of the kidney should be related to the echogenicity of either the liver or the spleen. Moreover, decreased kidney size and cortical thinning are also often seen and especially when disease progresses. However, kidney size correlates to height, and short persons tend to have small kidneys; thus, kidney size as
Focal segmental glomerulosclerosis - Misplaced Pages Continue
2368-422: Is in the middle (meso) between the capillaries (angis). It is contained by the basement membrane, which surrounds both the capillaries and the mesangium. The mesangium contains mainly: The glomerulus receives its blood supply from an afferent arteriole of the renal arterial circulation. Unlike most capillary beds, the glomerular capillaries exit into efferent arterioles rather than venules . The resistance of
2442-557: Is more than 30 mg/mmol, when blood pressure is difficult to control, or when hematuria or other findings suggest either a primarily glomerular disorder or secondary disease amenable to specific treatment. Other benefits of early nephrology referral include proper education regarding options for kidney replacement therapy as well as pre-emptive transplantation, and timely workup and placement of an arteriovenous fistula in those people with chronic kidney disease opting for future hemodialysis. At stage 5 CKD, kidney replacement therapy
2516-455: Is no difference in survival between the two groups. Quality of life might be better for people without dialysis. People who had decide against dialysis treatment when reaching end-stage chronic kidney disease could survive several years and experience improvements in their mental well-being in addition to sustained physical well-being and overall quality of life until late in their illness course. However, use of acute care services in these cases
2590-676: Is not certain that protein supplements affect quality of life, life expectancy, inflammation or body composition . Intravenous (IV) iron therapy may help more than oral iron supplements in reaching target hemoglobin levels. However, allergic reactions may also be more likely following IV-iron therapy. People with CKD experience sleep disorders, thus unable to get quality sleep. There are several strategies that could help, such as relaxation techniques, exercise, and medication. Exercise may be helpful with sleep regulation and possibly decreases fatigue and depression in people with CKD. However, none of these options have been proven to be effective in
2664-868: Is not known if they can also prevent death or cardiovascular events like heart complications or stroke. It is recommended that weight management interventions should be individualised, according to a thorough patients' assessment regarding clinical condition, motivations and preferences. High dietary sodium intake may increase the risk of hypertension and cardiovascular disease. The effect of dietary restriction of salt in foods has been investigated in people with chronic kidney disease. For people with CKD, including those on dialysis, reduced salt intake may help to lower both systolic and diastolic blood pressure, as well as albuminuria . Some people may experience low blood pressure and associated symptoms, such as dizziness, with lower salt intake. The effect of salt restriction on extracellular fluid, oedema, and total body weight reduction
2738-416: Is not known. EHealth interventions may improve dietary sodium intake and fluid management for people with CKD. In people with CKD who require hemodialysis, there is a risk that vascular blockage due to clotting , may prevent dialysis therapy from being possible. Even though Omega-3 fatty acids contribute to the production of eicosanoid molecules that reduce clotting, it does not have any impact on
2812-488: Is often required. While lower socioeconomic status contributes to the number of people affected with CKD, differences in the number of people affected by CKD are still evident between Africans and Whites when controlling for environmental factors. Although CKDu was first documented among sugar cane workers in Costa Rica in the 1970s, it may well have affected plantation labourers since the introduction of sugar cane farming to
2886-406: Is one of the forces that resist filtration. Because large and negatively charged proteins have a low permeability, they cannot filtrate easily to Bowman's capsule. Therefore, the concentration of these proteins tends to increase as the glomerular capillaries filtrate plasma, increasing the oncotic pressure along the glomerular capillary. The rate of filtration from the glomerulus to Bowman's capsule
2960-399: Is spanned by slit diaphragms consisting of a mat of proteins, including podocin and nephrin . In addition, foot processes have a negatively charged coat ( glycocalyx ) that repels negatively charged molecules such as serum albumin . The mesangium is a space which is continuous with the smooth muscles of the arterioles. It is outside the capillary lumen but surrounded by capillaries. It
3034-426: Is unknown, it is called idiopathic . Diagnosis of CKD is largely based on history , examination , and urine dipstick combined with the measurement of the serum creatinine level. Differentiating CKD from acute kidney injury (AKI) is important because AKI can be reversible. One diagnostic clue that helps differentiate CKD from AKI is a gradual rise in serum creatinine (over several months or years) as opposed to
Focal segmental glomerulosclerosis - Misplaced Pages Continue
3108-400: Is usually detected on routine screening blood work by either an increase in serum creatinine , or protein in the urine . As the kidney function decreases, more unpleasant symptoms may emerge: The most common causes of CKD are diabetes mellitus , hypertension , and glomerulonephritis . About one of five adults with hypertension and one of three adults with diabetes have CKD. If the cause
3182-418: Is usually required, in the form of either dialysis or a kidney transplant . In CKD numerous uremic toxins accumulate in the blood. Even when ESKD (largely synonymous with CKD5) is treated with dialysis, the toxin levels do not go back to normal as dialysis is not that efficient. Similarly, after a kidney transplant, the levels may not go back to normal as the transplanted kidney may not work 100%. If it does,
3256-400: The afferent arteriole , and the efferent arteriole . This arrangement of two arterioles in series determines the high hydrostatic pressure on glomerular capillaries, which is one of the forces that favor filtration to Bowman's capsule. If a substance has passed through the glomerular capillary endothelial cells, glomerular basement membrane , and podocytes , then it enters the lumen of
3330-1086: The Caribbean in the 1600s. In colonial times the death records of slaves on sugar plantations was much higher than for slaves forced into other labour. Denial of care in chronic kidney disease treatment and management is a significant issue for minority populations. This can be due to healthcare provider bias, structural barriers, and health insurance coverage disparities. Healthcare provider biases can lead to under-treatment, misdiagnosis, or delayed diagnosis. Structural barriers, such as lack of insurance and limited healthcare facilities, hinder access to timely care. Furthermore, health insurance coverage disparities, with minority populations lacking adequate coverage, contribute to these disparities. Denial of care worsens health outcomes and perpetuates existing health inequities. Race-based kidney function metrics, particularly normalizing creatinine, pose ethical challenges in diagnosing and managing chronic kidney disease (CKD). While certain racial and ethnic groups are at higher risk, using race as
3404-628: The breeds with the lowest rates. Cats with chronic kidney disease may have a buildup of waste products usually removed by the kidneys. They may appear lethargic, unkempt, and lose weight, and may have hypertension. The disease can prevent appropriate concentration of urine, causing cats to urinate greater volumes and drink more water to compensate. Loss of important proteins and vitamins through urine may cause abnormal metabolism and loss of appetite. The buildup of acids within blood can result in acidosis , which can lead to anemia (which can sometimes be indicated by pink or whitish gums, but by no means does
3478-599: The capillary architecture of the glomerulus and the continuity between its surrounding capsule and the proximal tubule. Chronic kidney disease Chronic kidney disease ( CKD ) is a type of long-term kidney disease , in which either there is a gradual loss of kidney function which occurs over a period of months to years, or an abnormal kidney structure (with normal function). Initially generally no symptoms are seen, but later symptoms may include leg swelling , feeling tired, vomiting , loss of appetite, and confusion . Complications can relate to hormonal dysfunction of
3552-614: The creatinine level is often normal. The toxins show various cytotoxic activities in the serum and have different molecular weights, and some of them are bound to other proteins, primarily to albumin. Uremic toxins are classified into three groups as small water-soluble solutes, middle molecular-weight solutes, and protein-bound solutes. Hemodialysis with high-flux dialysis membrane, long or frequent treatment, and increased blood/dialysate flow has improved removal of water-soluble small molecular weight uremic toxins. Middle molecular weight molecules are removed more effectively with hemodialysis using
3626-412: The descending and ascending loop of Henle and participate in the maintenance of the medullary countercurrent exchange system. The filtrate that has passed through the three-layered filtration unit enters Bowman's capsule. From there, it flows into the renal tubule—the nephron—which follows a U-shaped path to the collecting ducts , finally exiting into a renal calyx as urine . The main function of
3700-417: The effective pore size of the glomerular wall (8 nm). As a result, large and/or negatively charged molecules will pass through far less frequently than small and/or positively charged ones. For instance, small ions such as sodium and potassium pass freely, while larger proteins, such as hemoglobin and albumin have practically no permeability at all. The oncotic pressure on glomerular capillaries
3774-441: The efferent arteriole enters a renal venule , which in turn enters a renal interlobular vein and then into the renal vein . Cortical nephrons near the corticomedullary junction (15% of all nephrons) are called juxtamedullary nephrons . The blood exiting the efferent arterioles of these nephrons enter the vasa recta , which are straight capillary branches that deliver blood to the renal medulla . These vasa recta run adjacent to
SECTION 50
#17328589294203848-508: The efferent arterioles causes sufficient hydrostatic pressure within the glomerulus to provide the force for ultrafiltration . Blood exits the glomerular capillaries by an efferent arteriole instead of a venule , as is seen in the majority of capillary systems (Fig. 4). This provides tighter control over the blood flow through the glomerulus, since arterioles dilate and constrict more readily than venules, owing to their thick circular smooth muscle layer ( tunica media ). The blood exiting
3922-431: The efferent arterioles causes sufficient hydrostatic pressure within the glomerulus to provide the force for ultrafiltration . The glomerulus and its surrounding Bowman's capsule constitute a renal corpuscle , the basic filtration unit of the kidney. The rate at which blood is filtered through all of the glomeruli, and thus the measure of the overall kidney function, is the glomerular filtration rate . The glomerulus
3996-592: The filtration barrier, preventing molecules larger than 5 nm from being filtered. FSGS involves damage to the renal podocytes such that larger molecules, most notably proteins, are filtered and lost through the kidney. Thus, many of the signs and symptoms of FSGS are related to protein loss. On histology, FSGS manifests as scarring ( sclerosis ) to segments of glomeruli; moreover, only a portion of glomeruli are affected. The focal and segmental nature of disease seen on histology help to distinguish FSGS from other types of glomerular sclerosis . FSGS can be classified by
4070-477: The filtration of fluid, blood plasma solutes and protein, while at the same time preventing the filtration of red blood cells , white blood cells , and platelets . The glomerulus has a glomerular basement membrane sandwiched between the glomerular capillaries and the podocytes . It consists mainly of laminins , type IV collagen , agrin , and nidogen , which are synthesized and secreted by both endothelial cells and podocytes. The glomerular basement membrane
4144-437: The glomerular filtration barrier, which yields its filtrate of water and soluble substances to a cup-like sac known as Bowman's capsule . The filtrate then enters the renal tubule of the nephron. The glomerulus receives its blood supply from an afferent arteriole of the renal arterial circulation. Unlike most capillary beds, the glomerular capillaries exit into efferent arterioles rather than venules . The resistance of
4218-553: The glomerulus is to filter plasma to produce glomerular filtrate, which passes down the length of the nephron tubule to form urine. The rate at which the glomerulus produces filtrate from plasma (the glomerular filtration rate ) is much higher than in systemic capillaries because of the particular anatomical characteristics of the glomerulus. Unlike systemic capillaries, which receive blood from high-resistance arterioles and drain to low-resistance venules , glomerular capillaries are connected in both ends to high-resistance arterioles:
4292-447: The kidney disease and the risk of heart disease. Loop diuretics may be used to control edema and, if needed, to further lower blood pressure. NSAIDs should be avoided. Other recommended measures include staying active, and certain dietary changes such as a low-salt diet and the right amount of protein. Treatments for anemia and bone disease may also be required. Severe disease requires hemodialysis , peritoneal dialysis , or
4366-424: The kidney, the GFR does not indicate all aspects of kidney health and function. This can be done by combining the GFR level with the clinical assessment of the person, including fluid status, and measuring the levels of hemoglobin, potassium, phosphate, and parathyroid hormone. Kidney ultrasonography is useful for diagnostic and prognostic purposes in chronic kidney disease. Whether the underlying pathologic change
4440-550: The kidneys and include (in chronological order) high blood pressure (often related to activation of the renin–angiotensin system ), bone disease , and anemia . Additionally CKD patients have markedly increased cardiovascular complications with increased risks of death and hospitalization. CKD can lead to kidney failure requiring kidney dialysis or kidney transplantation . Causes of chronic kidney disease include diabetes , high blood pressure , glomerulonephritis , and polycystic kidney disease . Risk factors include
4514-486: The letter "P" to the stage of chronic kidney disease if protein loss is significant. The term "non-dialysis-dependent chronic kidney disease" (NDD-CKD) is a designation used to encompass the status of those persons with an established CKD who do not yet require the life-supporting treatments for kidney failure known as kidney replacement therapy (RRT, including maintenance dialysis or kidney transplantation ). The condition of individuals with CKD, who require either of
SECTION 60
#17328589294204588-406: The only parameter is not reliable. Additional tests may include nuclear medicine MAG3 scan to confirm blood flow and establish the differential function between the two kidneys. Dimercaptosuccinic acid (DMSA) scans are also used in kidney imaging; with both MAG3 and DMSA being used chelated with the radioactive element technetium-99 . A glomerular filtration rate (GFR) ≥ 60 mL/min/1.73 m
4662-894: The potential CKDu incidence. CKDu also affects people in Sri Lanka where it is the eighth largest cause of in-hospital mortality. African, Hispanics , and South Asians, particularly those from Pakistan, Sri Lanka, Bangladesh, and India, are at high risk of developing CKD. Africans are at greater risk due to the number of people affected with hypertension among them. As an example, 37% of ESKD cases in African Americans can be attributed to high blood pressure, compared with 19% among Caucasians. Treatment efficacy also differs between racial groups. Administration of antihypertensive drugs generally halts disease progression in white populations but has little effect in slowing kidney disease among black people, and additional treatment such as bicarbonate therapy
4736-436: The prevention of vascular blockage in people with CKD. Regular consumption of oral protein-based nutritional supplements may increase serum albumin levels slightly in people with CKD, especially among those requiring hemodialysis or who are malnourished. Prealbumin level and mid-arm muscle circumference may also be increased following supplementation. Despite possible improvement in these indicators of nutritional status, it
4810-524: The protein podocin found in podocytes; and INF2 , which encodes the actin-binding protein formin . The pathogenesis of HIV-associated FSGS is unclear, but may be due to the presence of the G1/G2 risk alleles of the APOL1 gene. There is some data to suggest that HIV can infect tubular epithelial cells and podocytes, but much remains to be known. Gain of function mutations in APOL1 have also been proposed to play
4884-411: The putative cause of damage to podocytes. Primary FSGS involves cases in which no cause is readily identifiable. It is presumed that a set of unidentified circulating factors in the blood contribute to podocyte damage in these cases. Secondary FSGS is caused by an identifiable stress or toxin that injures podocytes. Many causes of secondary FSGS contribute to podocyte injury through hyperfiltration, which
4958-407: The risk of major cardiovascular events such as myocardial infarction , stroke , heart failure , and death from cardiovascular disease when compared to placebo in individuals with CKD. ACEIs may be superior to ARBs for protection against progression to kidney failure and death from any cause in those with CKD. Aggressive blood pressure lowering decreases people's risk of death. Obesity may have
5032-664: The surgery. Transplantation aside, high-intensity home hemodialysis appears to be associated with improved survival and a greater quality of life, when compared to the conventional three-times-a-week hemodialysis and peritoneal dialysis . People with ESKD are at increased overall risk for cancer. This risk is particularly high in younger people and gradually diminishes with age. Medical specialty professional organizations recommend that physicians do not perform routine cancer screening in people with limited life expectancies due to ESKD because evidence does not show that such tests lead to improved outcomes. In children, growth failure
5106-458: The treatment of sleep disorders. This means that it is unknown what is the best guidance to improve sleep quality in this population. Guidelines for referral to a nephrologist vary between countries. Most agree that nephrology referral is required by Stage 4 CKD (when eGFR/1.73m is less than 30 mL/min; or decreasing by more than 3 mL/min/year). It may also be useful at an earlier stage (e.g. CKD3) when urine albumin-to-creatinine ratio
5180-420: The tubule and is known as glomerular filtrate. Otherwise, it exits the glomerulus through the efferent arteriole and continues circulation as discussed below and as shown on the picture. The structures of the layers determine their permeability -selectivity ( permselectivity ). The factors that influence permselectivity are the negative charge of the basement membrane and the podocytic epithelium, as well as
5254-584: The two types of kidney replacement therapy ( dialysis or transplant ), is referred to as the end-stage kidney disease (ESKD). Hence, the start of the ESKD is practically the irreversible conclusion of the NDD-CKD. Even though the NDD-CKD status refers to the status of persons with earlier stages of CKD (stages 1 to 4), people with advanced stage of CKD (stage 5), who have not yet started kidney replacement therapy, are also referred to as NDD-CKD. Chronic kidney disease (CKD)
5328-403: The urine ( urinalysis ) on microscopic and chemical (dipstick) examination. Glomerular diseases include diabetic kidney disease , glomerulonephritis (inflammation), glomerulosclerosis (hardening of the glomeruli), and IgA nephropathy . Due to the connection between the glomerulus and the glomerular filtration rate, the glomerular filtration rate is of clinical significance when suspecting
5402-455: Was 15.8 cases per 10,000 dog years at risk. The mortality rate of CKD was 9.7 deaths per 10,000 dog years at risk. (Rates developed from a population of 600,000 insured Swedish dogs; one dog year at risk is one dog at risk for one year). The breeds with the highest rates were the Bernese mountain dog , miniature schnauzer and boxer . The Swedish elkhound , Siberian husky and Finnish spitz were
5476-489: Was the cause of 956,000 deaths globally in 2013, up from 409,000 deaths in 1990. The cause of chronic kidney disease is in some cases not known; it is referred to as chronic kidney disease of unknown aetiology (CKDu). As of 2020 a rapidly progressive chronic kidney disease, unexplained by diabetes and hypertension, had increased dramatically in prevalence over a few decades in several regions in Central America and Mexico,
#419580